ConductScience.org, home

Paper · 24643196

Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias.

Andreassen KV and 7 others. PLoS One, 2014. Cited by 66 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias. Papers, record 24643196. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24643196

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias.
PubMed
Journal
PLoS One
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
66
iCite
Relative citation ratio, by iCite
2.16
iCite
Revised in PubMed
2021-10-21
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Andreassen KVKim Vietz
2Hjuler STSara Toftegaard
3Furness SGSebastian G
4Sexton PMPatrick M
5Christopoulos AArthur
6Nosjean OOlivier
7Karsdal MAMorten Asser
8Henriksen KKim

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CalcitoninMajor topic
Cyclic AMPMajor topic
Receptors, CalcitoninMajor topic
Signal TransductionMajor topic
Animals
Arrestins
Cell Line
Gene Expression Regulation
Humans
Ligands
Protein Transport
Salmon
Species Specificity
Time Factors
Transgenes
beta-Arrestins

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,847,755Cell cycle-dependent coupling of the calcitonin receptor to different G proteins.Science1991https://conductscience.org/library/papers/1847755PubMed
211,996,901Forty years of calcitonin--where are we now? A tribute to the work of Iain Macintyre, FRS.Bone2002https://conductscience.org/library/papers/11996901PubMed
37,723,741Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.Mol Pharmacol1995https://conductscience.org/library/papers/7723741PubMed
43,032,571Control of cyclic adenosine 3',5'-monophosphate production in osteoclasts: calcitonin-induced persistent activation and homologous desensitization of adenylate cyclase.Endocrinology1987https://conductscience.org/library/papers/3032571PubMed
520,161,833HTRF: A technology tailored for drug discovery - a review of theoretical aspects and recent applications.Curr Chem Genomics2009https://conductscience.org/library/papers/20161833PubMed
621,615,667A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet-induced obese rats.Diabetes Obes Metab2011https://conductscience.org/library/papers/21615667PubMed
715,119,591Photoaffinity scanning in the mapping of the peptide receptor interface of class II G protein-coupled receptors.J Pept Sci2004https://conductscience.org/library/papers/15119591PubMed
819,701,185Sustained cyclic AMP production by parathyroid hormone receptor endocytosis.Nat Chem Biol2009https://conductscience.org/library/papers/19701185PubMed
916,492,540Receptor pharmacology.Adv Pharmacol2005https://conductscience.org/library/papers/16492540PubMed
101,324,163Differential effects of the 3',5'-cyclic adenosine monophosphate and protein kinase C pathways on the response of isolated rat osteoclasts to calcitonin.Endocrinology1992https://conductscience.org/library/papers/1324163PubMed

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.

PMIDTitleJournalYearIn PapersSource
42,265,185Dual amylin and calcitonin receptor agonists as multifaceted disease-modifying osteoarthritis drugs.Int J Obes (Lond)2026https://conductscience.org/library/papers/42265185PubMed
41,268,902Functional characterization of neuropeptides that act as ligands for both calcitonin-type and pigment-dispersing factor-type receptors in a deuterostome.Elife2025https://conductscience.org/library/papers/41268902PubMed
40,925,966Structure-Encoded Location Biased Signaling in a Class B GPCR: Focus on the PTH Type 1 Receptor.Handb Exp Pharmacol2026https://conductscience.org/library/papers/40925966PubMed
40,828,907Amylin receptor subunit interactions are modulated by agonists and determine signaling.Sci Signal2025https://conductscience.org/library/papers/40828907PubMed
40,609,154Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3.EBioMedicine2025https://conductscience.org/library/papers/40609154PubMed
40,172,014Characterization of the Two-Domain Peptide Binding Mechanism of the Human CGRP Receptor for CGRP and the Ultrahigh Affinity ssCGRP Variant.Biochemistry2025https://conductscience.org/library/papers/40172014PubMed
40,168,114Prolonged signaling of backbone-modified glucagon-like peptide-1 analogues with diverse receptor trafficking.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40168114PubMed
39,185,315Assessing the immunogenicity risk of salmon calcitonin peptide impurities using in silico and in vitro methods.Front Pharmacol2024https://conductscience.org/library/papers/39185315PubMed
36,546,772New Insights into the Structure and Function of Class B1 GPCRs.Endocr Rev2023https://conductscience.org/library/papers/36546772PubMed
36,289,629The Impact of Exposure Profile on the Efficacy of Dual Amylin and Calcitonin Receptor Agonist Therapy.Biomedicines2022https://conductscience.org/library/papers/36289629PubMed

1 to 10 of 32

See all 32 cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ARRB1408PubTator's text mininghttps://conductscience.org/library/genes/408NCBI Gene
CALCA796PubTator's text mininghttps://conductscience.org/library/genes/796NCBI Gene
CALCR799PubTator's text mininghttps://conductscience.org/library/genes/799NCBI Gene
MAPK15,594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
VN1R17P441,931PubTator's text mininghttps://conductscience.org/library/genes/441931NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24643196

GET https://conductscience.org/api/papers/v1/24643196/references?page=2